Correlates of Adverse Events During Saphenous Vein Graft Intervention With Distal Embolic Protection. A PRIDE Substudy

JACC: Cardiovascular Interventions

Volumn 1, Issue 2, 2008, Pages 186-191

  Kirtane, Ajay J ^a   Heyman, Eugene R ^b   Metzger, Christopher ^c   Breall, Jeffrey A ^d   Carrozza Jr , Joseph P ^e  

^a NewYork Presbyterian Hospital   (United States)

^b The Heart Center ^*

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY   (United States)

^e Division of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; ADVERSE OUTCOME; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; CORRELATION ANALYSIS; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; SCORING SYSTEM; SURGICAL RISK; VEIN EMBOLISM;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CREATINE KINASE, MB FORM; EMBOLISM; FEMALE; GRAFT OCCLUSION, VASCULAR; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 41949131341     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.01.002     Document Type: Article

References (16)

1. Baim D.S., Wahr D., George B., et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105 (2002) 1285-1290
2. Stone G.W., Rogers C., Hermiller J., et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 108 (2003) 548-553
3. Giugliano G.R., Kuntz R.E., Popma J.J., Cutlip D.E., and Baim D.S. Determinants of 30-day adverse events after saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol 95 (2005) 173-177
4. Sievert H., Wahr D.W., Schuler G., et al. Effectiveness and safety of the Proxis system in demonstrating retrograde coronary blood flow during proximal occlusion and in capturing embolic material. Am J Cardiol 94 (2004) 1134-1139
5. Mauri L., Rogers C., and Baim D.S. Devices for distal protection during percutaneous coronary revascularization. Circulation 113 (2006) 2651-2656
6. Keeley E.C., Velez C.A., O'Neill W.W., and Safian R.D. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 38 (2001) 659-665
7. Sdringola S., Assali A.R., Ghani M., et al. Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention. Catheter Cardiovasc Interv 54 (2001) 318-324
8. Stone G.W., Rogers C., Ramee S., et al. Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. J Am Coll Cardiol 40 (2002) 1882-1888
9. Halkin A., Masud A.Z., Rogers C., et al. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial. Am Heart J 151 (2006) 915.e1-915.e7
10. Kalyanasundaram A., Blankenship J.C., Berger P., Herrmann H., McClure R., and Moliterno D. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do tirofiban and reopro give similar efficacy trial?). Catheter Cardiovasc Interv 69 (2007) 623-629 discussion 630-1
11. van Gaal W.J., Choudhury R.P., Porto I., et al. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 99 (2007) 603-606
12. Carrozza Jr. J.P., Mumma M., Breall J.A., Fernandez A., Heyman E., and Metzger C. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol 46 (2005) 1677-1683
13. Hong M.K., Mehran R., Dangas G., et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100 (1999) 2400-2405
14. Cohen D.J., Murphy S.A., Baim D.S., et al. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol 44 (2004) 1801-1808
15. Mehta S.K., Frutkin A.D., Milford-Beland S., et al. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol 100 (2007) 1114-1118
16. Liu M.W., Douglas J.S., Lembo N.J., and King S.B. Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts. Am J Cardiol 72 (1993) 514-517